Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma

Thyroid

Volumn 20, Issue 1, 2010, Pages 7-14

  Higashiyama, Takuya ^a   Ito, Yasuhiro ^a   Hirokawa, Mitsuyoshi ^a   Fukushima, Mitsuhiro ^a   Uruno, Takashi ^a   Miya, Akihiro ^a   Matsuzuka, Fumio ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; DEXAMETHASONE; GRANISETRON; PACLITAXEL; RANITIDINE;

ADJUVANT THERAPY; ADULT; AGED; ALOPECIA; ANAPLASTIC CARCINOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG FIBROSIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THYROID CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TIME FACTORS; TUMOR BURDEN;

EID: 75149189507     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0115     Document Type: Article

References (27)

1. Wartofsky L, Nostand DV 2007 Thyroid cancer. A Comprehensive Guide to Clinical Management, 2nd edition. Humana Press, Totowa, NJ.
2. International Union Against Cancer 2002 TNM Classification of Malignant Tumors, 6th edition. Wiley-Liss, New York.
3. Kihara M, Miyauchi A, Yamauchi A, Yokomise H 2004 Prognostic factors of anaplastic thyroid carcinoma. Surg Today 34:394-398.
4. Sugino K, Ito K, Mimura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H, Ito K 2002 The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 131:245-248.
5. Hirai K, Matsuzuka F, Miyauchi A, Kakudo K, Kuma K 1999 A clinical study of 30 cases of anaplastic thyroid carcinoma (ATC): clinical features of long-term survivors with ATC. Endocr Surg 16:25-30 (in Japanese).
6. Ito Y, Higashiyama T, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Tomoda C, Uruno T, Kihara M, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A 2009 Investigation of the validity of UICC stage grouping of anaplastic carcinoma of thyroid. Asian J Surg 32:47-50.
7. Kim JH, Leeper RD 1987 Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60:2372-2375.
8. Levendag PC, De Porre PMZR, van Putten WLJ 1993 Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys 26:125-128.
9. Ahuja S, Ernst H 1987 Chemotherapy of thyroid carcinoma. J Endocrinol Invest 10:303-310.
10. Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, De-Conti R 1985 A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155-2160.
11. Hoskin PJ, Harmer C 1987 Chemotherapy for thyroid cancer. Radiother Oncol 10:187-194.
12. Carcangiu ML, Steeper T, Zampi G, Rosai J 1985 Anaplastic thyroid carcinoma: a study of 70 cases. Am J Clin Pathol 83: 135-158.
13. Tsutsui K 1999 Chemotherapy for anaplastic thyroid carcinoma. Endocrine Surg 16:37-43 (in Japanese).
14. Nakayama T, Shiba E 2004 Optimal treatment of anaplastic thyroid cancer and malignant lymphoma of the thyroid gland. Rinsho Geka 59:437-442 (in Japanese).
15. Tsutsui H, Tsuboi M, Miyajima K, Suzuki A, Kubota M, Shibuya H, Sugino K, Ito K, Kato H 2005 The treatment strategy of anaplastic thyroid carcinoma. Geka Chiryo 93: 170-176 (in Japanese).
16. Marupudi NI, Han JE, Li KW 2007 Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609-621.
17. Ain KB, Egorin MJ, DeSimone PA 2000 Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Thyroid 10:587-594.
18. Taguchi T, Aihara T, Takatsuka Y, Shin E, Motomura K, Inaji H, Noguchi S 2004 Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan. Breast J 10:509-513.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG 2000 New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216.
20. Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH 1998 The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am 80:1020-1033.
21. Chen J, Tward JD, Shrieve DC, Hitchcock YJ 2008 Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. Am J Clin Oncol 31: 460-464.
22. Kim TY, Kim KW, Jung TS 2007 Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 8:765-772.
23. Yau T, Lo CY, Epstein RJ, Lam AK, Wan KY, Lang BH 2008 Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol 15:2500-2505.
24. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ 2002 The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57-64.
25. Besic N, Auersperg M, Us-Krasovec M, Golouh R, Frkovic-Grazio S, Vodnik A 2001 Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur J Surg Oncol 27:260-264.
26. Laird AK 1964 Dyanamics of tumor growth. Br J Cancer 13: 490-502.
27. Schabel FM Jr. 1975 Concepts for systemic treatment of micrometastases. Cancer 35:15-24.